EHRA Premium Access

Effects of upgrade versus de novo cardiac resyncrhonization therapy on clinical response. Long term survival follow up from single center.

Presentation

About the speaker

Doctor Rafaela Del Carmen Ramirez Rodriguez

University Hospital of Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria (Spain)
0 follower

19 more presentations in this session

Real World Data: Improvement of echocardiographic parameters, response and quality of life to Cardiac Resynchronization Therapy (CRT) continues up to 12 months after implantation

Speaker: Doctor F. Schiedat (Bochum, DE)

Thumbnail

Baseline characteristics and outcome of the resynchronization therapy in patients with valvular heart disease: single-center experience.

Speaker: Doctor T. Boumedien (Algiers, DZ)

Thumbnail

Sleep apnea detection by a cardiac resynchronization device integrated thoracic impedance sensor - a validation study against the gold standard polysomnography

Speaker: Doctor F. Barbieri (Berlin, DE)

Thumbnail

A super outcome to a super response

Speaker: Doctor V. Marinho (Coimbra, PT)

Thumbnail

Non-invasively assessed coronary flow reserve predicts survival in patients treated with cardiac resynchronization therapy

Speaker: Doctor V. Jovanovic (Belgrade, RS)

Thumbnail

Access the full session

Poster session 2 - CRT

Speakers: Doctor R. Ramirez Rodriguez, Doctor F. Schiedat, Doctor T. Boumedien, Doctor F. Barbieri, Doctor V. Marinho...
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk